ASIA BIOENERGY TECHNOLOGIES BERHAD - ICP
KLSE (MYR): ASIABIO-PR (0150PR)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.005
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Financial
T4Q
31-Mar-2021
2020
31-Mar-2021
2019
31-Mar-2021
2018
31-Mar-2021
2017
31-Mar-2021
Total assets
238
-1.64%
1000
+11.55%
110
+81.66%
900
-13.16%
600
+235.36%
Total current assets
238
1000
110
900
600
Cash & equivalents
238
1000
110
900
600
Short term investments
238
1000
110
900
600
Total receivables, net
238
1000
110
900
600
Accounts receivable - trade, net
238
1000
110
900
600
Other receivables
238
1000
110
900
600
Total inventory
238
1000
110
900
600
Inventories - work in progress
238
1000
110
900
600
Inventories - progress payments & other
238
1000
110
900
600
Inventories - finished goods
238
1000
110
900
600
Inventories - raw materials
238
1000
110
900
600
Total non-current assets
238
1000
110
900
600
Long term investments
238
1000
110
900
600
Note receivable - long term
238
1000
110
900
600
Investments in unconsolidated subsidiaries
238
1000
110
900
600
Other investments
238
1000
110
900
600
Net property/plant/equipment
238
1000
110
900
600
Gross property/plant/equipment
238
1000
110
900
600
Accumulated depreciation, total
238
1000
110
900
600
Deferred tax assets
238
1000
110
900
600
Net intangible assets
238
1000
110
900
600
Other current assets, total
238
1000
110
900
600
Total liabilities
238
-1.64%
1000
+11.55%
110
+81.66%
900
-13.16%
600
+235.36%
Total current liabilities
-238
-1000
-110
-900
-600
Total non-current liabilities
-238
-1000
-110
-900
-600
Long term debt
238
1000
110
900
600
Long term debt excl. lease liabilities
238
1000
110
900
600
Capital and operating lease obligations
238
1000
110
900
600
Provision for risks & charge
-238
-1000
-110
-900
-600
Deferred tax liabilities
-238
-1000
-110
-900
-600
Other liabilities, total
-238
-1000
-110
-900
-600
Total equity
-238
-1.64%
-1000
+11.55%
-110
+81.66%
-900
-13.16%
-600
+235.36%
Total liabilities & shareholders' equities
238B
1000B
110B
900B
600B
Total debt
238
1000
110
900
600
Book value per share
-238
-1000
-110
-900
-600
Discussions
Be the first to like this. Showing 26 of 26 comments
1)Buy 1 pr , subscribe 0.08 + cash 0.08 > convert to 1 ordinary share before 24/11/17. OrÂ
2)Buy 2 pr , subscribe 0.08 > convert into 1 ordinary share.Â
PR will cessation trading after 16/11/17 .
2017-11-06 08:45
For sweetening, every 10 PR subscribed un full, u are entitled for 1 warrant (exercise price at 0.150) :)
2017-11-06 08:48
need submit form for convert to ordinary share？ if 2pr convert to ordinary share need to pay 0.008 lagi？
2017-11-06 21:30
Posted by Lemon Tan > Nov 6, 2017 09:30 PM | Report AbuseÂ
need submit form for convert to ordinary share？ if 2pr convert to ordinary share need to pay 0.008 lagi？
ME :
Direct account holders may fill in Rights Subscribe Form(RSF) and issue your Banker Draft before 24/12/17 to subsribe for the rights u bought or entitled.
2pr rights in fully subscribed ($0.08 x 2), need not top up cash upon maturity for convert.
1 right subscribed in full, only need to + 0.08 cash top up during matured for converting.
2017-11-06 21:47
@VenFx
I hd acquired the RSF, found out that only mention ICPS+free warrant. No ASIABIO-PR can convert to mother share . Why?
2017-11-12 09:12
Asiabio-Pr(preserved right) is a temporary items to be trade open market till 24/11/17.
In order to let the traders to buy or sales in the market.
Investors only can convert their icps (after the 'pr' subscribed in full), upon investors surrender their icps for cancellation in order to convert into ordinary share.
Pls always consult your broker to seek furthur explanation.
As i might not explanation as whole of the processes.
2017-11-12 12:32
Sorry, Pr only trade in open market till 16/11/17
Last acceptance for subscription and payment on 24/11/17
2017-11-12 12:48
8 PR for 1 mother share conversion and 1 PR subscribe at 8. cts so mother must be worth 8 times 8 = 64 cts but mother now only 20 cts , so tomorrow mother share must fly like hell to make PR viable....or can someone help to explain as. I bought WA at 6 cts which I think should fly to 34 c t s if mother go to 64cts
2017-11-12 13:44
My broker say they are trying to confuse people with their interpretation to push up the mother and wa like crazy next week,,,
2017-11-12 14:22
like tat more worth to subscription to mother share..currently mother share 0.20..
2017-11-16 15:45
Hi all sifus, please help, how can I change the PR into mother share？ I do not have any broker
2017-11-17 15:49
Hihi, I get the RSF already from Bursa, , but inside there, they require some field like Number of shares held on 2 November 2017, which I do not have, I only bought the ASIABIO-PR without the mothershare. In this case, how can I fill in the RSF ya? Is it possible to convert by using using the ASIABIO-PR ?
2017-11-20 23:00
Just fill in the excess application site to subscribe,
To convert , u may do it only after the subscriptions, by surrender and cancell your right share.
Last payment date is 24/nov/17
2017-11-20 23:09
lifelyms - if you don't buy/pay the RSF by 5 pm today..you are going to be hit by 0.005 (if not mistaken) x number of units U bought. Remember bank close at what time..Easiest go to Bangsar South - get the bank draft from RHB and Tricor is just opposite the lobby....
2017-11-24 08:00
VenFx comment on Dec 20, 2017Â Â
Stock: [ANZO]: ANZO HOLDINGS BHDÂ Â
 Dec 20, 2017 01:02 AM | Report Abuse  Â
Go buy MIECO @ 0.920 early morning.  Â
Xmast small gift for u .Â
21/12/2017 14:11Â
please explain to your comment above, mieco presently price at 0.825. you con every one in anzo to buy MIECO for you to escape from your contra dealing. bloody evil contra player VenFx aka fortunee
2017-12-21 17:31
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
THE INVESTMENT APPROACH OF CALVIN TAN
3
4
5
7
MQ Market Updates
8
Good Articles to Share
Congress to vote on new restrictions on US investment in China
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
lifelyms
Anyone know what is this PR?
2017-11-03 10:02